Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates

Clinical trial NCT00517062 · COMPLETED

Trial details

NCT number: NCT00517062
Sponsor: Oregon Health and Science University
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Growth Hormone Deficiency

Start date: 2006-01-01
Primary completion: 2012-01-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.